Published in Lancet on April 15, 2000
A Different Approach to Preventing Thrombosis (ADAPT) | NCT02774265
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 3.63
von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood (2010) 2.82
Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies. PLoS One (2016) 1.52
Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 1.31
Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial. CMAJ (2013) 1.20
Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. CMAJ (2005) 1.18
Preventing atherosclerotic events with aspirin. BMJ (2002) 1.18
Prevention of venous thromboembolism in spinal surgery. Eur Spine J (2003) 1.12
Thromboprophylaxis after replacement arthroplasty. BMJ (2001) 1.10
Extracts from "clinical evidence": hip fracture. BMJ (2001) 1.08
Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty (2009) 1.07
Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res (2013) 1.05
Thromboembolic events with lenalidomide-based therapy for multiple myeloma. Cancer (2008) 1.03
Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg (2013) 1.02
Foot pumps without graduated compression stockings for prevention of deep-vein thrombosis in total joint replacement: efficacy, safety and patient compliance. A comparative, prospective clinical trial. Int Orthop (2007) 0.99
Osteoporotic fractures in older adults. Best Pract Res Clin Rheumatol (2006) 0.95
Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international survey. Ann R Coll Surg Engl (2010) 0.95
Effect of inpatient quality of care on functional outcomes in patients with hip fracture. Med Care (2006) 0.93
Little impact of antiplatelet agents on venous thromboembolism after hip fracture surgery. J Korean Med Sci (2011) 0.92
Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studies. Can J Gastroenterol (2013) 0.91
Thromboprophylaxis in surgical patients. Can J Surg (2003) 0.91
The role of dyslipidemia and statins in venous thromboembolism. Curr Control Trials Cardiovasc Med (2001) 0.90
Assessment and reporting of perioperative cardiac risk by Canadian general internists: art or science? J Gen Intern Med (2002) 0.86
Deep vein thrombosis and pulmonary embolism - Prevention, management, and anaesthetic considerations. Indian J Anaesth (2010) 0.85
Measurement of thrombosis and its prevention. Br J Clin Pharmacol (2002) 0.85
Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev (2010) 0.85
Post-discharge symptomatic thromboembolic events in hip fracture patients. Ann R Coll Surg Engl (2007) 0.85
Analysis on the pathogenesis of symptomatic pulmonary embolism with human genomics. Int J Med Sci (2012) 0.84
Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty? Clin Orthop Relat Res (2014) 0.83
Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology. Syst Rev (2014) 0.81
Clopidogrel in Orthopaedic patients: a review of current practice in Scotland. Thromb J (2007) 0.81
Myocardial ischaemia after hip and knee arthroplasty: incidence and risk factors. Int Orthop (2015) 0.80
Addition of lenalidomide to melphalan in the treatment of newly diagnosed multiple myeloma: the National Cancer Institute of Canada Clinical Trials Group MY.11 trial. Curr Oncol (2007) 0.80
Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance. Ther Adv Drug Saf (2012) 0.80
Use of a haemostatic matrix (Floseal(®)) does not reduce blood loss in minimally invasive total knee arthroplasty performed under continued aspirin. Blood Transfus (2015) 0.80
Medical management in the acute hip fracture patient: a comprehensive review for the internist. Ochsner J (2012) 0.79
Fatal pulmonary embolism after arthroscopic rotator cuff repair: a case series. Muscles Ligaments Tendons J (2014) 0.79
Early functional results after hemiarthroplasty for femoral neck fracture: a randomized comparison between a minimal invasive and a conventional approach. BMC Musculoskelet Disord (2012) 0.79
Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol (2010) 0.79
Hip fracture. BMJ Clin Evid (2010) 0.79
Gastric protection and gastrointestinal bleeding with aspirin thromboprophylaxis in hip and knee joint replacements. Ann R Coll Surg Engl (2008) 0.79
Aspirin mono-therapy continuation does not result in more bleeding after knee arthroplasty. Knee Surg Sports Traumatol Arthrosc (2015) 0.78
Aspirin and multiple sclerosis. BMC Med (2015) 0.78
Combination of raloxifene, aspirin and estrogen as novel paradigm of hormone replacement therapy in rabbit model of menopause. Acta Pharmacol Sin (2011) 0.78
Venous thromboembolic prophylaxis for hip fractures. Osteoporos Int (2010) 0.78
Place of aspirin in prophylaxis of venous thromboembolism. Lancet (2000) 0.78
Preventing deep vein thrombosis in hospital inpatients. BMJ (2007) 0.78
Thromboprophylaxis and orthopaedic surgery: options and current guidelines. Malays J Med Sci (2014) 0.78
Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations. Int Orthop (2013) 0.78
Symptomatic venous thromboembolism following a hip fracture. Acta Orthop (2009) 0.78
Antipsychotics and risk of venous thromboembolism: A population-based case-control study. Clin Epidemiol (2009) 0.77
New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism. Ther Clin Risk Manag (2015) 0.77
Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis. J Thromb Haemost (2016) 0.77
Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban. Clin Pharmacol (2013) 0.76
A Pilot Study Comparing Hospital Readmission Rates In Patients Receiving Rivaroxaban or Enoxaparin After Orthopedic Surgery. P T (2016) 0.75
New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplasty. World J Orthop (2014) 0.75
Perioperative Management to Reduce Cardiovascular Events. Circulation (2016) 0.75
Pharmacologic prophylaxis and treatment of venous thromboembolism after knee arthroplasty. Sultan Qaboos Univ Med J (2007) 0.75
Deep vein thrombosis in a patient of adenomatous polyposis coli treated successfully with aspirin: A case report. Caspian J Intern Med (2016) 0.75
Prevention and Treatment of Lower Limb Deep Vein Thrombosis after Radiofrequency Catheter Ablation: Results of a Prospective active controlled Study. Sci Rep (2016) 0.75
Thromboembolic events are uncommon after open treatment of proximal humerus fractures using aspirin and compression devices. Clin Orthop Relat Res (2011) 0.75
Mechanical prophylaxis after hip fracture: what is the risk of deep vein thrombosis? A retrospective observational study. BMJ Open (2015) 0.75
Cohort feasibility study of an intermittent pneumatic compression device within a below-knee cast for the prevention of venous thromboembolism. BMJ Open (2016) 0.75
Multiple Myeloma: Cast Nephropathy, VTE, and Neurologic Complications. J Adv Pract Oncol (2013) 0.75
Progressive wound necrosis associated with postoperative thrombocytosis in mastectomy and immediate breast reconstruction surgery: report of a case. Eplasty (2009) 0.75
Medical risks during flight deportation of refugees. Int J Equity Health (2003) 0.75
Venous Thromboembolism (VTE) Prophylaxis for Hip and Knee Arthroplasty: Changing Trends. Curr Rev Musculoskelet Med (2014) 0.75
Community nurse resource implications for a change in heparin prophylaxis policy. SICOT J (2015) 0.75
Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study. Thromb Res (2017) 0.75
Generalisations on benefits of aspirin are dangerous. BMJ (2000) 0.75
Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS). Thromb Res (2015) 0.75
Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis. J Am Heart Assoc (2015) 0.75
Comparison of postoperative complications after total hip arthroplasty among patients receiving aspirin, enoxaparin, warfarin, and factor Xa inhibitors. J Orthop (2017) 0.75
Association between aspirin use and deep venous thrombosis in mechanically ventilated ICU patients. J Thromb Thrombolysis (2017) 0.75
Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review. Support Care Cancer (2014) 0.75
The clinical results of a novel method for minimal invasive dynamic hip screw fixation of intertrochanteric fractures compared to the conventional one. Eur J Trauma Emerg Surg (2016) 0.75
[Does acetylsalicylic acid have a negative influence on photodynamic therapy?]. Ophthalmologe (2006) 0.75